Solinger; Alan M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Solinger; Alan M..The latest application filed is for "methods for the treatment of gout".

Company Profile

2.15.17

Solinger; Alan M. - US
Solinger; Alan M. - Berkeley CA
Solinger; Alan M. - Ridgefield CT
Solinger; Alan M. - Oakland CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods For The Treatment Of Gout App 20210032326 - Solinger; Alan M.	2021-02-04
Cardiovascular Related Uses Of Il-1beta Antibodies And Binding Fragments Thereof App 20210009679 - Scannon; Patrick J. ; et al.	2021-01-14
Cardiovascular related uses of IL-1.beta. antibodies and binding fragments thereof Grant 10,611,832 - Scannon , et al.	2020-04-07
Cardiovascular Related Uses Of Il-1beta Antibodies And Binding Fragments Thereof App 20180155420 - Scannon; Patrick J. ; et al.	2018-06-07
Methods For The Treatment Of Gout App 20170355764 - Solinger; Alan M.	2017-12-14
Methods for the treatment of IL-1.beta. related diseases Grant 9,163,082 - Solinger , et al. October 20, 2	2015-10-20
Methods for the treatment of uveitis with IL-1.beta. binding antibodies Grant 9,139,646 - Solinger , et al. September 22, 2	2015-09-22
Methods For The Treatment Of Gout App 20140370002 - Solinger; Alan M.	2014-12-18
Methods For The Treatment Of Il-1beta Related Diseases App 20140255391 - Solinger; Alan M. ; et al.	2014-09-11
Methods For The Treatment Of Il-1beta Related Conditions App 20140242090 - Solinger; Alan M. ; et al.	2014-08-28
Methods for the treatment of gout Grant 8,637,029 - Solinger January 28, 2	2014-01-28
Methods For Improvement Of Beta Cell Function App 20140017249 - Scannon; Patrick J. ; et al.	2014-01-16
Methods for the treatment of IL-1.beta. related diseases Grant 8,586,036 - Solinger , et al. November 19, 2	2013-11-19
Methods for the treatment of IL-1.beta. related conditions Grant 8,551,487 - Solinger , et al. October 8, 2	2013-10-08
Methods for treating IL-1.beta. related diseases by administering an anti-IL-1.beta. antibody Grant 8,545,846 - Scannon , et al. October 1, 2	2013-10-01
Methods for improvement of beta cell function with anti-IL-1.beta. antibodies or fragments thereof Grant 8,377,429 - Scannon , et al. February 19, 2	2013-02-19
Methods for the treatment of IL-1.beta. related diseases Grant 8,101,166 - Solinger , et al. January 24, 2	2012-01-24
Methods For The Treatment Of Il-1beta Related Conditions App 20120014966 - Solinger; Alan M. ; et al.	2012-01-19
Methods For Treating Or Preventing Il-1beta Related Diseases App 20120003226 - Scannon; Patrick J. ; et al.	2012-01-05
Methods For Improvement Of Beta Cell Function App 20120005127 - Scannon; Patrick J. ; et al.	2012-01-05
Methods For The Treatment Of Rheumatoid Arthritis App 20110189172 - Solinger; Alan M. ; et al.	2011-08-04
Methods For The Treatment Of Il-1beta Related Diseases App 20110038859 - Solinger; Alan M. ; et al.	2011-02-17
Cardiovascular Related Uses Of Il-1beta Antibodies And Binding Fragments Thereof App 20100316651 - SCANNON; PATRICK J. ; et al.	2010-12-16
Methods For The Treatment Of Il-1beta Related Diseases App 20100303807 - Solinger; Alan M. ; et al.	2010-12-02
Methods for the treatment of IL-1.beta. related diseases Grant 7,695,718 - Solinger , et al. April 13, 2	2010-04-13
Methods for the Treatment of Gout App 20090181019 - Solinger; Alan M.	2009-07-16
Methods For The Treatment Of Il-1beta Related Diseases App 20080292640 - Solinger; Alan M. ; et al.	2008-11-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.